ARTICLE | Company News
KS Biomedix licenses antibodies to York Medical
November 2, 2000 8:00 AM UTC
York Medical received a license to co-develop KH-6H9Chi, an antibody to treat colon cancer from KS Biomedix (LSE:KSB). York will have the right to commercialize the product in the Americas, while KSB ...